Nursing care
Hashimoto Thyroiditis nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Hashimoto thyroiditis is an autoimmune disease and the most common cause of hypothyroidism in developed countries. Diagnosis rests on elevated anti-thyroid peroxidase antibodies, and treatment is lifelong levothyroxine replacement with periodic TSH monitoring, not a course of medication that ends.
What it is and why it happens
Hashimoto thyroiditis is an autoimmune condition in which lymphocytic infiltration of the thyroid gland gradually destroys thyroid tissue, most often mediated by anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin antibodies. The gland is slowly disabled rather than acutely damaged, which is why the onset of hypothyroid symptoms is typically gradual.
It is, by a wide margin, the most common cause of hypothyroidism in countries where dietary iodine is adequate. It occurs more often in women and has a genetic and familial component, so a family history of thyroid or other autoimmune disease is a relevant finding on history-taking, not an incidental detail.
How it presents — what you will actually see
Early disease can be subclinical, with a normal or only mildly elevated TSH and few symptoms, or the patient may present with a firm, non-tender, diffusely enlarged goitre. As the gland fails, expect the classic hypothyroid picture: fatigue, cold intolerance, weight gain, constipation, dry skin, hair thinning, and bradycardia.
Patients often describe a slow decline that they attribute to ageing or stress rather than illness, which is why unexplained fatigue with weight gain deserves a thyroid panel. Some patients cycle through a brief hyperthyroid phase early on, from inflammatory release of stored hormone, before settling into the hypothyroid state that defines the disease long term.
Nursing assessment priorities
Assess for goitre by inspecting and palpating the neck, and note that in Hashimoto the gland is typically firm and finely nodular or 'pebbly' rather than smooth. Assess heart rate, since bradycardia and reduced cardiac output are expected findings as hypothyroidism progresses.
Review lab work with the diagnosis in mind: an elevated TSH with a low free T4 confirms hypothyroidism, but it is the elevated anti-TPO antibody titre that identifies Hashimoto specifically as the cause rather than another aetiology. Ask about mood changes and cognitive slowing too, since these are commonly under-reported by patients themselves.
Interventions and what to do first
The primary intervention is levothyroxine replacement, started at a low dose in older adults or those with cardiac disease and titrated upward based on TSH response. Teach the patient to take it on an empty stomach, first thing in the morning, at least 30 to 60 minutes before food, and to keep dosing consistent since absorption is affected by food, calcium, and iron supplements.
Monitor for symptom improvement over weeks rather than days, since thyroid hormone replacement works gradually. Address symptomatic complaints directly in the meantime: warm environment for cold intolerance, bowel regimen for constipation, and skin care for dryness, while the medication takes effect.
Complications to watch for
Myxedema coma is the rare but life-threatening complication of severe, untreated hypothyroidism: hypothermia, hypotension, bradycardia, and decreased level of consciousness. It is a medical emergency requiring IV levothyroxine and often IV hydrocortisone, since coexisting adrenal insufficiency must be covered.
Because Hashimoto is autoimmune, patients carry a higher risk of other autoimmune conditions, including type 1 diabetes, vitiligo, pernicious anaemia and celiac disease, so unexplained new symptoms in a different system are worth investigating rather than dismissing. Over-replacement with levothyroxine can also produce iatrogenic hyperthyroidism, so monitoring cuts both ways.
Patient teaching before discharge
The central teaching point is that levothyroxine is a lifelong medication, not a short course, because Hashimoto causes permanent, progressive loss of thyroid function. Reinforce consistent timing, empty-stomach dosing, and spacing doses away from calcium and iron supplements by at least four hours.
Teach the patient to expect periodic TSH monitoring, typically starting around six to eight weeks after a dose change, and to report symptoms of both under-replacement (fatigue, cold intolerance, weight gain) and over-replacement (palpitations, tremor, anxiety, weight loss). Stress that missing doses or stopping the medication will cause symptoms to return, since the underlying gland damage does not reverse.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our endocrine practice questions are the closest set to what this page covers.
Common questions
Is Hashimoto thyroiditis the same as hypothyroidism?
Not exactly. Hashimoto thyroiditis is the autoimmune disease process that causes hypothyroidism in most patients in the developed world. Hypothyroidism is the resulting biochemical state; Hashimoto is the underlying cause.
How is Hashimoto thyroiditis confirmed?
A raised TSH with a low free T4 shows hypothyroidism, but an elevated anti-thyroid peroxidase antibody titre confirms Hashimoto as the specific cause. Ultrasound may also show a diffusely heterogeneous gland.
Is levothyroxine a permanent medication for Hashimoto?
Yes, in almost all cases. Hashimoto causes ongoing, irreversible loss of thyroid tissue, so levothyroxine replacement is generally lifelong, with the dose adjusted over time based on TSH results.
How soon should TSH be rechecked after starting levothyroxine?
TSH is typically rechecked about six to eight weeks after starting or adjusting the dose, since thyroid hormone levels take time to stabilise. Dosing is adjusted based on that result rather than on symptoms alone.